Neurological

Deep brain stimulation works by targeting specific areas of the brain with electrical impulses, and a study has demonstrated how it can be customized based on individual brain activity to treat depression resistant to traditional forms of therapy.

Research tracking rates of autism in England has found a striking 787 percent increase in the volume of diagnoses over the past 20 years. The growth is most likely thought to be due to increased reporting and greater detection of the condition in adults.

Do you have a brain for math? New research indicates levels of two key neurotransmitters can predict mathematics ability, suggesting brain chemistry may be playing a role in those who find math easy.

A new study has detected cognitive deficits in recovered COVID-19 patients, finding the more severe the case, the greater the persistent cognitive problems, with hospitalized patients put on ventilators showing a decline equivalent to seven IQ points.

An extraordinary new study is reporting the first direct demonstration of a psilocybin dose inducing neural plasticity in a mammalian brain. The researchers hypothesize this mechanism playing a role in the drug’s antidepressant qualities.

A detailed investigation into brain tissue from those who died from COVID-19 has found no trace of the SARS-CoV-2 virus, but “profound molecular markers of inflammation” were seen offering clues to explain long COVID symptoms.

In a new study, occipital nerve stimulation has been found to reduce the frequency and severity of headaches in patients suffering chronic cluster headaches, and the results suggest low doses of electrical stimulation are as effective as high doses.

Scientists at the University of Tokyo have come up with novel approach to tackling brain plaques associated with Alzheimer's, clearing them through the use of injectable, oxygenated atoms that are activated by infrared light.

A robust new study has comprehensively demonstrated how SARS-CoV-2, the coronavirus that causes COVID-19, can infect the brain and central nervous system. The study validates a growing body of research attributing neurological issues to COVID-19.

Scientists studying the mechanisms behind cellular stress and its effects on aging have found success in reversing cognitive decline in mice using an experimental drug, which bodes well for further study of aging and its effects in human subjects.

Research has suggested that anxiety is an early indicator for Alzheimer's disease, which often follows mild cognitive decline (MCI). A new study has now found a link between anxiety and an increased rate of progression from MCI to Alzheimer's disease.

A UK team has demonstrated a novel technology for imaging the brains of infants and babies. The breakthrough is hoped to allow researchers new ways to investigate baby brain activity in natural environments without the need for expensive MRI machines.